tiprankstipranks
pc:epibi

EpiBiologics

EpiBiologics is a biotech company developing tissue-selective extracellular protein degradation therapeutics using a proprietary modular bispecific antibody platform (EpiTAC). The company focuses on targeted degradation of disease-driving membrane and soluble proteins to create novel therapies in oncology and immunology.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$107M
Total Amount Raised$107M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$107M
Latest Funding Amount$107M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jan 08, 2026
Series B
$107.00M

Investors

Investor Name
Funding Round

Related News and Analysis